Showing 421 - 440 results of 229,702 for search '(( 5 ((non decrease) OR (mean decrease)) ) OR ( 10 ((we decrease) OR (a decrease)) ))', query time: 1.85s Refine Results
  1. 421
  2. 422
  3. 423

    Decreasing ShcA expression enhances TGF-β-induced Smad signaling. by Baby Periyanayaki Muthusamy (838234)

    Published 2015
    “…The error bars show standard error of the mean, based on three independent experiments. Supplemental data are shown in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1002325#pbio.1002325.s006" target="_blank">S5 Fig</a> and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1002325#pbio.1002325.s001" target="_blank">S1 Data</a>.…”
  4. 424

    Regulatory B10 cells are augmented and the level of IL-10 expression is decreased in the spleen of AD mice. by Jieqiong Li (327149)

    Published 2015
    “…<p>(A) Representative dot-plots showing the percentage of CD5<sup>+</sup>CD19<sup>+</sup>CD1d<sup>hi</sup> B10 cells in control (n = 10) and AD mice (n = 10); (B) Bar graph depicting the percentage of CD5<sup>+</sup>CD19<sup>+</sup>CD1d<sup>hi</sup>B10 cells in control and AD mice as analyzed by flow cytometry. …”
  5. 425
  6. 426
  7. 427
  8. 428
  9. 429
  10. 430
  11. 431
  12. 432
  13. 433
  14. 434
  15. 435
  16. 436
  17. 437
  18. 438

    Decreased Memory B Cells and Increased CD8 Memory T Cells in Blood of Breastfed Children: The Generation R Study by Michelle A. E. Jansen (740955)

    Published 2015
    “…</p><p>Results</p><p>Per month continuation of breastfeeding, a 3% (95% CI -6, -1) decrease in CD27+IgM+, a 2% (95 CI % -5, -1) decrease in CD27+IgA+ and a 2% (95% CI -4, -1) decrease in CD27-IgG+ memory B cell numbers were observed at 6 months of age. …”
  19. 439
  20. 440

    Table_1_A phased intervention bundle to decrease the mortality of patients with extracorporeal membrane oxygenation in intensive care unit.pdf by Yajun Jing (11711139)

    Published 2022
    “…</p>Results<p>The cohort included 297 patients in 6 ICUs, mostly VA ECMO (68.7%) with a median (25th–75th percentile) duration in ECMO of 9.0 (4.0–15.0) days. The mean (SD) APECHII score was 24.1 (7.5). Overall, the mortality of ECMO decreased from 57.1% at baseline to 21.8% at 13–18 months after implementation of the study intervention (P < 0.001). …”